Table of contents
October 2004 Vol 4 No 10
In this issue
p749 | doi:10.1038/nrc1471
Research Highlights
Oncogenes: Keeping track of STATs | PDF (109 KB)
p750 | doi:10.1038/nrc1463
Genetics: Extra extra | PDF (88 KB)
p751 | doi:10.1038/nrc1464
Trial Watch
Predictions are circulating | PDF (88 KB)
p751 | doi:10.1038/nrc1470
Lung cancer: Smoking out differences | PDF (104 KB)
p752 | doi:10.1038/nrc1460
In brief
Genetics | Breast Cancer | Therapeutics | Technology | PDF (104 KB)
p752 | doi:10.1038/nrc1465
Tumorigenesis: Inflammatory debate | PDF (140 KB)
p753 | doi:10.1038/nrc1461
In the news
Data collecting dust | PDF (140 KB)
p753 | doi:10.1038/nrc1466
Tumorigenesis: Two faces of hypoxia | PDF (102 KB)
p754 | doi:10.1038/nrc1459
Immunology: Deregulation required? | PDF (200 KB)
p754 | doi:10.1038/nrc1468
Pharmacogenomics: ABCs of drug resistance | PDF (154 KB)
p755 | doi:10.1038/nrc1469
Tumorigenesis: Dependence on independence | PDF (116 KB)
p756 | doi:10.1038/nrc1462
Metastasis: Coming unstuck | PDF (116 KB)
p756 | doi:10.1038/nrc1467
Reviews
Epstein–Barr virus: 40 years on
Lawrence S. Young & Alan B. Rickinson
p757 | doi:10.1038/nrc1452
Genetic predisposition to colorectal cancer
Albert de la Chapelle
p769 | doi:10.1038/nrc1453
Polyamines and cancer: old molecules, new understanding
Eugene W. Gerner & Frank L. Meyskens, Jr
p781 | doi:10.1038/nrc1454
Post-translational modification of p53 in tumorigenesis
Ann M. Bode & Zigang Dong
p793 | doi:10.1038/nrc1455
High interstitial fluid pressure — an obstacle in cancer therapy
Carl-Henrik Heldin, Kristofer Rubin, Kristian Pietras & Arne Östman
p806 | doi:10.1038/nrc1456
Perspectives
Opinion
Hallmarks of 'BRCAness' in sporadic cancers
Nicholas Turner, Andrew Tutt & Alan Ashworth
p814 | doi:10.1038/nrc1457
Opinion
A vision for the National Cancer Program in the United States
Andrew C. von Eschenbach
p820 | doi:10.1038/nrc1458